Advertisement LGC expands nucleic acid extraction service capacity in North America - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

LGC expands nucleic acid extraction service capacity in North America

LGC Genomics has expanded its nucleic acid extraction service capacity into North America.

The extraction service will complement the company’s existing capacity in Berlin, Germany and London, UK and will be delivered from the genomics laboratory in Beverly, Massachusetts , US.

LGC global laboratory operations head Steve Asquith said the expansion will offer DNA and RNA extraction and genotyping services to its customers.

"DNA extraction is a necessary step before any genotyping work can be undertaken and this added capacity will allow us to provide greater support than ever before to an expanding global customer base – including many multinational research teams," Asquith added.

"The range of extraction solutions we provide, combined with our applications expertise, sets us apart and our laboratory experts deliver fit-for-purpose solutions that yield DNA of the appropriate quality and quantity for downstream processing.

"And of course once developed, optimized protocols are readily made available to customers for use in their own labs should they desire to do the work themselves."